De-identified Human Tissue Project for Use with Translational, Biomedical Research At UCF College of Medicine and Burnett School of Biomedical Sciences
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Tissue
- Sponsor
- University of Central Florida
- Enrollment
- 1000000
- Locations
- 1
- Primary Endpoint
- Receipt of de-identified human tissue for research
- Status
- Recruiting
- Last Updated
- last year
Overview
Brief Summary
Research scientists of the University of Central Florida College of Medicine (COM) and Burnett School of Biomedical Sciences (BSBS) conduct laboratory studies in biomedical and translational medical research for the purpose of understanding human disease and developing innovative methods for diagnosing, measuring, or treating disease or disease symptoms. The key research divisions are cancer, cardiovascular, immunity and pathogenesis, neuroscience, and molecular microbiology.
Detailed Description
The objective of this De-Identified Human Tissue Project is the receipt of de-identified human tissue from medical, surgical, and clinical facilities. The human tissue can be fresh or paraffinized. The human tissue will be picked up by the clinical research team and transferred to research scientists of the University of Central Florida's College of Medicine (COM) or Burnett School of Biomedical Sciences (BSBS) for storage and testing according to their separate IRB-approved or IRB-exempted protocols. These separate protocols cannot be for genetic testing. The Project does not receive human tissue resulting from termination of pregnancy.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Receipt of de-identified human tissue for research
Time Frame: 5 years
The key research divisions are cancer, cardiovascular, immunity and pathogenesis, neuroscience, and molecular microbiology. Frequently, these studies require human tissue for testing of assays and devices.